Feline Toxoplasmosis: Neurological Manifestations and Fecal Transmission

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-06-06

Key Takeaways

• Feline toxoplasmosis, caused by Toxoplasma gondii, is characterized by fecal transmission of environmentally resistant oocysts shed by definitive feline hosts.
• Neurological manifestations in cats can range from seizures and ataxia to behavioral changes and blindness, often resulting from tachyzoite invasion of the central nervous system.
• Risk factors for feline toxoplasmosis include outdoor access, hunting, and raw meat consumption, with co-infection by FIV or FeLV significantly increasing the risk of severe disease, including neurological involvement.
• Diagnosis relies on a combination of serological assays (IgG, IgM ELISA), molecular methods (PCR on blood, CSF, or feces), and clinical signs, with recombinant antigens like MIC17A showing promise for feline-specific detection.
• Treatment typically involves clindamycin (10-12 mg/kg q12h for 2-4 weeks) or a sulfadiazine/trimethoprim combination, with prognosis guarded in immunocompromised individuals.
• Prevention strategies focus on minimizing environmental contamination through daily litter box cleaning, feeding cooked diets, and preventing cats from hunting, thereby reducing the risk of oocyst shedding and subsequent infection.

Introduction

Toxoplasma gondii is an obligate intracellular apicomplexan parasite that infects virtually all warm-blooded vertebrates [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. Felids, including domestic cats, serve as the definitive hosts in which the sexual phase of the life cycle occurs, leading to the excretion of environmentally resistant oocysts [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>]. This unique role makes cats central to the epidemiology of toxoplasmosis [<a href="#ref-4">4</a>]. Feline infection can result in a spectrum of clinical outcomes ranging from subclinical carriage to severe systemic disease, with neurological involvement being a particularly important manifestation [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>, <a href="#ref-7">7</a>]. Fecal transmission of oocysts, commonly referred to as toxoplasmosis in cat poop, represents the primary route of environmental contamination and subsequent infection of intermediate hosts [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>, <a href="#ref-3">3</a>]. This reference article provides an exhaustive review of the neurological manifestations and fecal transmission of feline toxoplasmosis, incorporating recent advances in diagnostics and an understanding of pathogenetic mechanisms.

Etiology and Life Cycle

T. gondii exists in three infectious stages: tachyzoites (rapidly dividing), bradyzoites (slowly dividing within tissue cysts), and sporozoites (within oocysts) [<a href="#ref-1">1</a>, <a href="#ref-8">8</a>]. Cats typically acquire infection by ingesting tissue cysts containing bradyzoites from infected prey or raw meat [<a href="#ref-3">3</a>, <a href="#ref-8">8</a>]. After ingestion, bradyzoites excyst in the small intestine and invade enterocytes, initiating an enteroepithelial cycle that culminates in the production of oocysts [<a href="#ref-2">2</a>, <a href="#ref-9">9</a>]. This sexual replication is restricted to the feline intestinal tract [<a href="#ref-1">1</a>]. Oocysts are shed unsporulated in feces and sporulate in the environment within 1 to 5 days, becoming infectious [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>]. Sporulated oocysts can survive for months under favorable conditions [<a href="#ref-4">4</a>]. Concurrently, the parasite may disseminate via the lymphatics and blood as tachyzoites, invading diverse tissues including the brain, muscle, and eyes [<a href="#ref-5">5</a>, <a href="#ref-7">7</a>]. In immunocompetent cats, immune pressure drives conversion to bradyzoites, forming tissue cysts that persist for life [<a href="#ref-8">8</a>, <a href="#ref-10">10</a>]. Reactivation of chronic infection can occur during immunosuppression, leading to recrudescent disease [<a href="#ref-10">10</a>, <a href="#ref-11">11</a>, <a href="#ref-12">12</a>].

Epidemiology

Feline toxoplasmosis is distributed globally, with seroprevalence varying by geographic region, lifestyle, and diagnostic method [<a href="#ref-3">3</a>, <a href="#ref-13">13</a>, <a href="#ref-14">14</a>]. Studies report seropositivity rates from 8.6% in domiciled kittens to 57.9% in adult stray cats in the United States [<a href="#ref-15">15</a>]. In Kuwait, IgG and IgM prevalence of 60% and 31.7% respectively were documented [<a href="#ref-13">13</a>]. A nationwide study in Greece found 21.8% seropositivity using a rapid immunochromatographic test, with hunting and outdoor access identified as significant risk factors [<a href="#ref-3">3</a>]. Similar risk factors (rural habitat, hunting, raw feeding) have been reported in Brazil [<a href="#ref-16">16</a>, <a href="#ref-17">17</a>], Finland [<a href="#ref-14">14</a>], and Russia [<a href="#ref-18">18</a>]. Age, gender, and retroviral co-infections may influence seroprevalence and clinical expression [<a href="#ref-3">3</a>, <a href="#ref-17">17</a>, <a href="#ref-19">19</a>]. Co-infection with feline immunodeficiency virus (FIV) or feline leukemia virus (FeLV) is associated with more severe disease and increased risk of neurological toxoplasmosis [<a href="#ref-11">11</a>, <a href="#ref-12">12</a>, <a href="#ref-19">19</a>].

Neurological Manifestations: Cat Toxoplasmosis Brain

Neurological involvement in feline toxoplasmosis, often termed cat toxoplasmosis brain, can result from primary infection or reactivation of latent cysts [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>, <a href="#ref-12">12</a>]. Tachyzoites invade the central nervous system (CNS) by crossing the blood-brain barrier, either as free parasites or within infected leukocytes [<a href="#ref-7">7</a>]. Once in the brain parenchyma, they cause focal necrosis, microglial nodules, and perivascular inflammation [<a href="#ref-7">7</a>, <a href="#ref-12">12</a>]. Clinical signs reflect the location and extent of lesions [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>].

Common neurological signs include seizures (generalized or partial), ataxia, circling, head pressing, behavioral changes (aggression, depression), blindness, and proprioceptive deficits [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>, <a href="#ref-20">20</a>]. Meningoencephalitis may manifest with fever, hyperesthesia, and cranial nerve deficits [<a href="#ref-7">7</a>, <a href="#ref-20">20</a>]. Spinal cord involvement can cause paresis or paralysis [<a href="#ref-7">7</a>]. In a series of 15 clinical cases, neurological signs were present in 7 cats, with 5 showing seizures [<a href="#ref-6">6</a>]. Cerebral toxoplasmosis has been documented in cats with concurrent retroviral infections, including FIV and FeLV, and in cats with feline infectious peritonitis (FIP) [<a href="#ref-11">11</a>, <a href="#ref-12">12</a>]. Oclacitinib therapy for allergic skin disease in an FIV-positive cat triggered fatal disseminated toxoplasmosis with CNS involvement [<a href="#ref-11">11</a>]. Ocular toxoplasmosis, often presenting as anterior uveitis, can accompany neurological disease [<a href="#ref-21">21</a>]. In a study of 60 seropositive cats with ocular signs, 63% had anterior uveitis and 20% had posterior segment involvement [<a href="#ref-21">21</a>].

Pathological Findings

Gross pathological changes in the brain may be absent even in severe cases [<a href="#ref-7">7</a>]. Histologically, the hallmark is multifocal necrotizing encephalitis with areas of gliosis and perivascular cuffing by mononuclear cells [<a href="#ref-7">7</a>, <a href="#ref-12">12</a>]. Free tachyzoites and tissue cysts can be identified within neurons, astrocytes, and microglial cells [<a href="#ref-7">7</a>]. In immunocompromised cats, lesions are more extensive and contain larger numbers of tachyzoites [<a href="#ref-11">11</a>, <a href="#ref-12">12</a>]. A case of cerebral toxoplasmosis in a cat co-infected with FeLV and FIP revealed numerous tachyzoites in the cerebrum, cerebellum, and brainstem, with minimal inflammatory response [<a href="#ref-12">12</a>]. Spinal cord lesions include myelitis and necrosis [<a href="#ref-7">7</a>].

Fecal Transmission: Toxoplasmosis in Cat Poop

The shedding of oocysts in feces is the defining feature of feline toxoplasmosis from a transmission perspective [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>, <a href="#ref-4">4</a>]. After primary infection with bradyzoites, cats begin shedding oocysts within 3 to 10 days, and shedding typically persists for 1 to 3 weeks [<a href="#ref-8">8</a>, <a href="#ref-9">9</a>]. Oocyst output can be enormous: millions per day [<a href="#ref-4">4</a>]. Shedding is often subclinical and transient, making detection challenging [<a href="#ref-1">1</a>, <a href="#ref-15">15</a>]. Cats can also re-shed oocysts after reinfection, though immunity reduces the likelihood [<a href="#ref-10">10</a>, <a href="#ref-22">22</a>]. Tachyzoite or oocyst ingestion may also induce shedding, albeit with different dynamics [<a href="#ref-9">9</a>].

Once shed, sporulated oocysts contaminate soil, water, and surfaces [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>]. They are highly resistant to environmental conditions and can survive for months to years [<a href="#ref-4">4</a>]. Fecal contamination of cat litter boxes, gardens, and sandboxes poses a risk for intermediate hosts, including humans [<a href="#ref-3">3</a>]. Studies examining toxoplasmosis in cat poop have found low oocyst detection rates in natural populations due to intermittent shedding [<a href="#ref-15">15</a>, <a href="#ref-23">23</a>]. However, molecular detection using PCR has improved sensitivity for identifying oocysts in fecal samples [<a href="#ref-1">1</a>].

Diagnostic Approaches

Accurate diagnosis of feline toxoplasmosis requires integration of serological, molecular, and clinical data [<a href="#ref-1">1</a>, <a href="#ref-24">24</a>, <a href="#ref-25">25</a>]. Serological assays detect IgG and IgM antibodies. IgG indicates past or chronic infection; IgM suggests recent or active infection [<a href="#ref-13">13</a>, <a href="#ref-21">21</a>]. Commercially available immunochromatographic tests provide rapid point-of-care results, but their sensitivity and specificity vary [<a href="#ref-3">3</a>, <a href="#ref-13">13</a>]. Enzyme-linked immunosorbent assay (ELISA) using tachyzoite lysate antigen (TLA) is a reference method, but recombinant antigens offer safer, standardized alternatives [<a href="#ref-26">26</a>]. Microneme protein 17A (MIC17A) is highly expressed in merozoites (enteroepithelial stages) and has been proposed as a diagnostic marker specific for feline infection [<a href="#ref-2">2</a>, <a href="#ref-27">27</a>]. Recombinant antigens including SAG2, GRA2, GRA6, GRA7, GRA15, and MIC10 have been evaluated in combination, achieving performance comparable to TLA [<a href="#ref-26">26</a>].

Molecular methods (PCR) detect T. gondii DNA in blood, cerebrospinal fluid (CSF), aqueous humor, or feces [<a href="#ref-1">1</a>, <a href="#ref-21">21</a>]. PCR is particularly useful for confirming active infection and for detecting oocysts in feces [<a href="#ref-1">1</a>]. Emerging nanomaterial-enhanced assays and artificial intelligence-based diagnostic algorithms promise to improve stage-specific detection [<a href="#ref-1">1</a>]. The diagnostic decision tree is illustrated in Figure 1.

flowchart TD
 A["Clinical suspicion of feline toxoplasmosis"] --> B{"Neurological signs?"}
 B -->|"Yes"| C["CSF analysis: PCR + antibody index"]
 B -->|"No"| D{"Ocular signs?"}
 D -->|"Yes"| E["Aqueous humor PCR + serology"]
 D -->|"No"| F["Serology: IgG & IgM ELISA"]
 C --> G["Positive PCR or elevated antibody index?"]
 G -->|"Yes"| H["Probable CNS toxoplasmosis"]
 G -->|"No"| I["Consider other causes"]
 E --> J["Positive PCR or local antibody production?"]
 J -->|"Yes"| K["Probable ocular toxoplasmosis"]
 J -->|"No"| L["Other uveitis etiology"]
 F --> M{"IgM positive or rising IgG?"}
 M -->|"Yes"| N["Active infection - treat"]
 M -->|"No"| O["Chronic infection - assess risk factors"]
 N --> P["Fecal PCR for oocyst shedding"]
 P --> Q["Positive: environmental contamination risk"]
 P --> R["Negative: no active shedding"]

Table 1 summarizes the main diagnostic methods and their characteristics.

Treatment and Management

The cornerstone of treatment for clinical feline toxoplasmosis is clindamycin, administered orally or parenterally at 10 to 12 mg/kg every 12 hours for 2 to 4 weeks [<a href="#ref-6">6</a>, <a href="#ref-24">24</a>]. A combination of sulfadiazine and trimethoprim is also used [<a href="#ref-21">21</a>, <a href="#ref-29">29</a>]. In a study of 15 clinical cases, 13 cats responded to clindamycin therapy within 48 hours [<a href="#ref-6">6</a>]. Ocular toxoplasmosis may require additional topical corticosteroids or mydriatics [<a href="#ref-21">21</a>]. Immunocompromised cats, such as those with FIV or FeLV, may require prolonged therapy and guarded prognosis [<a href="#ref-11">11</a>, <a href="#ref-19">19</a>]. In one case, oclacitinib therapy was associated with fatal toxoplasmosis, indicating caution with immunosuppressive drugs in seropositive cats [<a href="#ref-11">11</a>]. Supportive care includes fluid therapy, nutritional support, and anticonvulsants for seizure control [<a href="#ref-6">6</a>, <a href="#ref-24">24</a>]. Phosprenyl (polyprenyl phosphate) has been studied in cats with concurrent coronavirus infection and toxoplasmosis, showing improvement in hematologic and biochemical parameters [<a href="#ref-29">29</a>]. Long-term management aims to prevent recrudescence: minimizing stress, avoiding immunosuppressive agents, and maintaining good nutrition [<a href="#ref-10">10</a>, <a href="#ref-24">24</a>].

Control and Prevention

Given the central role of fecal transmission, control of toxoplasmosis in cats focuses on reducing environmental contamination with oocysts (toxoplasmosis in cat poop) [<a href="#ref-4">4</a>, <a href="#ref-30">30</a>]. Key measures include: (1) preventing cats from hunting by keeping them indoors or using bells; (2) feeding only cooked or commercial diets; (3) daily cleaning of litter boxes (oocysts require 1 to 5 days to sporulate); (4) careful disposal of cat feces; and (5) covering children's sandboxes when not in use [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>, <a href="#ref-30">30</a>]. Serologic screening can identify cats that are actively shedding or at risk for reactivation [<a href="#ref-1">1</a>, <a href="#ref-16">16</a>, <a href="#ref-25">25</a>]. Vaccination of cats is not currently widely available, although research continues [<a href="#ref-1">1</a>]. Public education remains essential to mitigate zoonotic risk [<a href="#ref-4">4</a>, <a href="#ref-13">13</a>].

References

Related Clinical & Scientific Guides

• Tick-Borne Diseases in Dogs: Pathogens, Clinical Signs, Diagnosis, and Prevention
• Toxoplasmosis in Cats and the Risk of Brain Infection in Humans
• Dog Heartworm and Tick-Borne Disease Prevention